61 related articles for article (PubMed ID: 11501176)
1. Enzyme kinetics and inhibition of nimodipine metabolism in human liver microsomes.
Liu XQ; Ren YL; Qian ZY; Wang GJ
Acta Pharmacol Sin; 2000 Aug; 21(8):690-4. PubMed ID: 11501176
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and metabolic inhibition of cilnidipine in human liver microsomes.
Liu XQ; Zhao Y; Li D; Qian ZY; Wang GJ
Acta Pharmacol Sin; 2003 Mar; 24(3):263-8. PubMed ID: 12617777
[TBL] [Abstract][Full Text] [Related]
3. CYP3A4 mediated in vitro metabolism of vinflunine in human liver microsomes.
Zhao XP; Zhong J; Liu XQ; Wang GJ
Acta Pharmacol Sin; 2007 Jan; 28(1):118-24. PubMed ID: 17184591
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic kinetics of MN9202 in Beagle dog liver microsomes].
Yang ZF; Zhou SY; Mei QB; Yang TH; Liu ZG
Yao Xue Xue Bao; 2005 Nov; 40(11):1019-23. PubMed ID: 16499087
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation.
Obach RS
Drug Metab Dispos; 2000 Sep; 28(9):1069-76. PubMed ID: 10950851
[TBL] [Abstract][Full Text] [Related]
6. Differential metabolism of midazolam in mouse liver and intestine microsomes: a comparison of cytochrome P450 activity and expression.
Perloff MD; Von Moltke LL; Greenblatt DJ
Xenobiotica; 2003 Apr; 33(4):365-77. PubMed ID: 12745872
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and metabolic inhibition of gambogic acid in rat liver microsomes.
Liu YT; Hao K; Liu XQ; Wang GJ
Acta Pharmacol Sin; 2006 Sep; 27(9):1253-8. PubMed ID: 16923348
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of mono-hydroxylation of daidzein in human liver microsomes].
Peng WX; Li HD; Zhou HH
Yao Xue Xue Bao; 2004 Nov; 39(11):892-6. PubMed ID: 15696928
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of alfentanil by cytochrome p4503a (cyp3a) enzymes.
Klees TM; Sheffels P; Dale O; Kharasch ED
Drug Metab Dispos; 2005 Mar; 33(3):303-11. PubMed ID: 15557344
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of para toluene-sulfonamide metabolism and effect with regard to CYP isoforms, P-glycoprotein, and drug interactions.
Zhou JQ; Tang ZQ; Zhang JN
Pharmazie; 2006 Oct; 61(10):869-73. PubMed ID: 17069428
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems.
Baranczewski P; Edlund PO; Postlind H
J Pharm Biomed Anal; 2006 Mar; 40(5):1121-30. PubMed ID: 16307862
[TBL] [Abstract][Full Text] [Related]
12. Role of rat liver cytochrome P450 3A and 2D in metabolism of imrecoxib.
Xu HY; Xie ZY; Zhang P; Sun J; Chu FM; Guo ZR; Zhong DF
Acta Pharmacol Sin; 2006 Mar; 27(3):372-80. PubMed ID: 16490176
[TBL] [Abstract][Full Text] [Related]
13. Formation of 4'-carboxyl acid metabolite of imrecoxib by rat liver microsomes.
Xu HY; Zhang P; Gong AS; Sun YM; Chu FM; Guo ZR; Zhong DF
Acta Pharmacol Sin; 2006 Apr; 27(4):506-12. PubMed ID: 16539853
[TBL] [Abstract][Full Text] [Related]
14. Effects of cytochrome P450 inhibitors on peroxidase activity.
Martinkova M; Kubickova B; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():33-40. PubMed ID: 23353841
[TBL] [Abstract][Full Text] [Related]
15. Sequential metabolism is responsible for diltiazem-induced time-dependent loss of CYP3A.
Zhao P; Lee CA; Kunze KL
Drug Metab Dispos; 2007 May; 35(5):704-12. PubMed ID: 17293381
[TBL] [Abstract][Full Text] [Related]
16. Characterization of benidipine and its enantiomers' metabolism by human liver cytochrome P450 enzymes.
Yoon YJ; Kim KB; Kim H; Seo KA; Kim HS; Cha IJ; Kim EY; Liu KH; Shin JG
Drug Metab Dispos; 2007 Sep; 35(9):1518-24. PubMed ID: 17537876
[TBL] [Abstract][Full Text] [Related]
17. [Study on metabolism of tetramethylpyrazine in system of rat liver microsomes].
Kuang XD; Li XH; Xiong YQ
Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):1971-5. PubMed ID: 17348193
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
Usmani KA; Hodgson E; Rose RL
Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.
Cherstniakova SA; Bi D; Fuller DR; Mojsiak JZ; Collins JM; Cantilena LR
Drug Metab Dispos; 2001 Sep; 29(9):1216-20. PubMed ID: 11502731
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
Kitamura A; Mizuno Y; Natsui K; Yabuki M; Komuro S; Kanamaru H
Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]